ABSI | Absci Corporation

Index- P/E- EPS (ttm)-1.08 Insider Own0.70% Shs Outstand91.48M Perf Week13.77%
Market Cap165.45M Forward P/E- EPS next Y-0.71 Insider Trans0.00% Shs Float62.84M Perf Month52.00%
Income-98.80M PEG- EPS next Q-0.24 Inst Own48.10% Short Float / Ratio6.72% / 8.98 Perf Quarter-5.47%
Sales6.20M P/S26.69 EPS this Y44.40% Inst Trans4.14% Short Interest4.22M Perf Half Y-17.21%
Book/sh2.78 P/B0.68 EPS next Y25.30% ROA-29.90% Target Price7.73 Perf Year-50.90%
Cash/sh1.66 P/C1.15 EPS next 5Y20.40% ROE-34.70% 52W Range1.13 - 7.04 Perf YTD-9.52%
Dividend- P/FCF- EPS past 5Y- ROI-36.90% 52W High-73.01% Beta-
Dividend %- Quick Ratio6.10 Sales past 5Y- Gross Margin- 52W Low68.14% ATR0.20
Employees193 Current Ratio6.10 Sales Q/Q62.50% Oper. Margin- RSI (14)64.23 Volatility15.56% 13.25%
OptionableYes Debt/Eq0.05 EPS Q/Q21.90% Profit Margin- Rel Volume1.34 Prev Close1.93
ShortableYes LT Debt/Eq0.03 EarningsMay 15 AMC Payout- Avg Volume470.35K Price1.90
Recom2.60 SMA2033.90% SMA5021.07% SMA200-26.50% Volume628,307 Change-1.55%
Date Action Analyst Rating Change Price Target Change
May-04-23Initiated H.C. Wainwright Buy $4
Aug-12-22Downgrade JP Morgan Overweight → Underweight
Jul-18-22Initiated Truist Buy $8
Mar-02-22Resumed Cowen Market Perform
Feb-01-22Initiated Berenberg Buy $28
Nov-10-21Downgrade BofA Securities Neutral → Underperform $10
Oct-15-21Resumed Cowen Market Perform
Aug-16-21Initiated Stifel Hold $28
Aug-16-21Initiated Credit Suisse Outperform $40
Aug-16-21Initiated Cowen Market Perform
Aug-16-21Initiated BofA Securities Neutral $26
May-15-23 05:45PM
04:05PM
May-11-23 08:00AM
May-03-23 10:00AM
Apr-06-23 08:00AM
08:00AM Loading…
Apr-04-23 08:00AM
Apr-01-23 08:25AM
Mar-30-23 04:05PM
Mar-23-23 08:00AM
Mar-07-23 08:00AM
06:08AM
Feb-28-23 08:00AM
Feb-21-23 08:00AM
Feb-09-23 08:00AM
Feb-08-23 08:00AM
10:36AM Loading…
Jan-10-23 10:36AM
10:00AM
08:00AM
Jan-08-23 03:13PM
Dec-29-22 07:17AM
Dec-28-22 08:00AM
Nov-23-22 08:00AM
Nov-17-22 08:00AM
Nov-09-22 10:47AM
09:15AM
08:00AM
Nov-02-22 04:05PM
08:00AM
Oct-26-22 08:00AM
Oct-04-22 07:00AM
06:44AM Loading…
Sep-28-22 06:44AM
Sep-01-22 08:00AM
Aug-24-22 07:00AM
Aug-15-22 04:00PM
Aug-11-22 09:15AM
08:00AM
Aug-10-22 10:50AM
08:19AM
Aug-02-22 11:17AM
Aug-01-22 08:00AM
Jul-26-22 02:23PM
Jul-22-22 07:25AM
Jul-21-22 07:00AM
Jul-14-22 07:05AM
Jul-07-22 07:05AM
Jun-16-22 05:48PM
Jun-14-22 06:06PM
Jun-13-22 11:37AM
11:37AM
May-30-22 06:18AM
May-12-22 02:29PM
May-11-22 08:00AM
May-03-22 08:55AM
Apr-28-22 07:00AM
Apr-26-22 06:23PM
Apr-20-22 08:03AM
07:00AM
Mar-22-22 04:05PM
01:19PM
01:00PM
Mar-21-22 04:05PM
Mar-16-22 08:00AM
Mar-11-22 09:41AM
Mar-01-22 08:00AM
Feb-25-22 10:47AM
Feb-17-22 08:00AM
Feb-11-22 08:00AM
Jan-12-22 10:13AM
Jan-10-22 06:00PM
10:07AM
Jan-07-22 11:29AM
08:56AM
08:22AM
05:00AM
05:00AM
Jan-06-22 04:27PM
Jan-05-22 04:05PM
Dec-30-21 08:05AM
Dec-29-21 06:51PM
04:05PM
Nov-28-21 07:58PM
Nov-25-21 11:41PM
Nov-22-21 02:59PM
Nov-21-21 11:20PM
Nov-18-21 04:21PM
Nov-15-21 11:28PM
04:14PM
09:56AM
Nov-11-21 05:50PM
Nov-10-21 06:32AM
Nov-09-21 07:00AM
Nov-01-21 02:29PM
Oct-28-21 04:05PM
Oct-22-21 06:04AM
Oct-20-21 04:05PM
Oct-14-21 04:05PM
Oct-11-21 11:16AM
Oct-06-21 04:59PM
06:00AM
Sep-22-21 08:00AM
Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHIFFMAN GREGORY TChief Financial OfficerOct 20Option Exercise1.1050,00055,000605,165Oct 24 05:54 PM